This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1qs4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1qs4" size="450" color="white" frame="true" align="right" spinBox="true" caption="1qs4, resolution 2.10&Aring;" /> '''CORE DOMAIN OF HIV-...)
Next diff →

Revision as of 12:18, 8 November 2007


1qs4, resolution 2.10Å

Drag the structure with the mouse to rotate

CORE DOMAIN OF HIV-1 INTEGRASE COMLEXED WITH MG++ AND 1-(5-CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H-TETRAZOL-5-YL)-PROPENONE

Overview

HIV integrase, the enzyme that inserts the viral DNA into the host, chromosome, has no mammalian counterpart, making it an attractive target, for antiviral drug design. As one of the three enzymes produced by HIV, it, can be expected that inhibitors of this enzyme will complement the, therapeutic use of HIV protease and reverse transcriptase inhibitors. We, have determined the structure of a complex of the HIV-1 integrase core, domain with a novel inhibitor, 5ClTEP, 1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)-pro penone, to 2.1-A, resolution. The inhibitor binds centrally in the active site of the, integrase and makes a number of close contacts with the protein. Only, minor changes in the protein accompany inhibitor binding. This inhibitor, complex will provide a platform for structure-based design of an, additional class of inhibitors for antiviral therapy.

About this Structure

1QS4 is a Single protein structure of sequence from Human immunodeficiency virus 1 with MG and 100 as ligands. Active as RNA-directed DNA polymerase, with EC number 2.7.7.49 Full crystallographic information is available from OCA.

Reference

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design., Goldgur Y, Craigie R, Cohen GH, Fujiwara T, Yoshinaga T, Fujishita T, Sugimoto H, Endo T, Murai H, Davies DR, Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13040-3. PMID:10557269

Page seeded by OCA on Thu Nov 8 14:24:58 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools